Volume 11, Number 12—December 2005
Postepizootic Persistence of Venezuelan Equine Encephalitis Virus, Venezuela
|Sample no.†||% inhibition of epizootic–specific MAb 1A3A–5 binding at indicated serum dilution
||% inhibition of enzootic–specific MAb 1A1B–9 binding at indicated serum dilution
*ELISA, enzyme-linked immunosorbent assay; VEEV, Venezuelan equine encephalitis virus; HI, hemagglutination-inhibition; PRNT, plaque reduction neutralization test; MAb, monoclonal antibody.
†Negative controls are bovine sera from locations with no history of VEE; positive controls are human sera from virus isolation–confirmed, subtype ID VEEV infections (note that the assay is species–independent).
- Page created: February 02, 2012
- Page last updated: February 02, 2012
- Page last reviewed: February 02, 2012
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)